Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > CEO said, "we are undervalued". Okay, so how what is an
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(602)
•••
Comment by subaru1ion Apr 20, 2024 11:44am
61 Views
Post# 35999517

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CEO said, "we are undervalued". Okay, so how what is an

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CEO said, "we are undervalued". Okay, so how what is an VIVO provided state of the art grow operations, you are correct.   Did Tilray see the legislative changes writing on the wall w.r.t. to Tilray's dronabinol production, ie, not having the same pharmaceutical certifications as LABS and the agreement with LABS was to sustains Tilray's presence in the German market place?....we think that is the case.   The agreement is over a '4 year period' and giving Tilray the time needed to pursue higher level pharma certifications and the LABS agreement is a stop gap measure otherwise Tilray would be shut out of the dronabinol market.  
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities